MediPharm Labs Corp. (OTCMKTS:MEDIF) Short Interest Update

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the target of a significant decline in short interest during the month of February. As of February 13th, there was short interest totaling 71,786 shares, a decline of 56.9% from the January 29th total of 166,605 shares. Based on an average daily trading volume, of 227,635 shares, the short-interest ratio is presently 0.3 days. Based on an average daily trading volume, of 227,635 shares, the short-interest ratio is presently 0.3 days.

MediPharm Labs Price Performance

MediPharm Labs stock opened at $0.05 on Friday. MediPharm Labs has a fifty-two week low of $0.04 and a fifty-two week high of $0.09. The company’s 50 day simple moving average is $0.05 and its 200 day simple moving average is $0.05.

About MediPharm Labs

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.